Actively Recruiting
Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia: A Mixed-Methods Assessment
Led by University of British Columbia · Updated on 2026-02-17
710
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Malnutrition among pregnant women in low- and middle-income countries can lead to micronutrient deficiencies causing negative effects on maternal and newborn health. The World Health Organization recommends multiple micronutrient supplementation (MMS), including iron and folic acid, during pregnancy to improve these outcomes. This study evaluates the implementation of MMS in Takeo Province, Cambodia, to understand health system readiness and inform nationwide scale-up. The study focuses on the transition from iron and folic acid supplementation to MMS across all health centers and hospitals in Takeo. Data collection involves mixed methods including focus group discussions with health providers, interviews with hospital managers and national stakeholders, workload surveys, supply monitoring, and phone surveys with pregnant women consuming MMS. These activities assess provider adherence, acceptability, resource needs, supply reliability, and economic factors related to MMS delivery. Participants include pregnant women receiving antenatal care in Takeo, healthcare providers, facility managers, and national officials. Women are followed up via phone surveys at 90 and 180 days after receiving MMS to assess adherence and acceptability. Provider workload and resource gaps are assessed, and perspectives on MMS integration into services are gathered. The study aims to generate insight into real-world implementation, identify challenges and adaptations needed, and support sustainable national MMS scale-up in Cambodia.
CONDITIONS
Brief Title
Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Currently pregnant
- At least 18 years of age
- Have attended at least one antenatal care visit at a health center or hospital in Takeo during the study period
- Can provide a functioning phone number for follow-up contact
- Willing to participate and provide consent
You will not qualify if you...
- Diagnosed anemia requiring iron and folic acid supplementation instead of MMS
- Unable to communicate via telephone
- Withdraws consent at any point
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or phone)
Duration - Up to 6 months
Participants who consume multiple micronutrient supplements (MMS) during pregnancy are observed to understand adherence and perspectives on MMS integration into antenatal services.
Periodic phone follow-ups and surveys during pregnancy
Duration - Up to 4 months
Health center providers, hospital managers, and national stakeholders participate in focus group discussions and interviews to assess health system readiness and resource needs for MMS delivery.
Multiple interviews and focus group discussions (FGDs)
Trial Site Locations
Total: 1 location
1
Takeo province
Phnom Penh, Cambodia
Actively Recruiting
Research Team
M
Meng Sokchea Program Manager, Helen Keller International, MD
V
Vannary Hun, MPH
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here